GPC Biotech AG(Frankfurt Stock Exchange:GPC;TecDAX 30;NASDAQ:GPCB)and Debiopharm S.A.,the independent drug-development company specializing in oncology,endocrinology and niche products,have signed a license agreement for GPC Biotech's pre-clinical small molecule MHC class II antagonists program.Under...
Martinsried (Germany), March 13, 2001 -- GPC Biotech AG (Frankfurt Stock Exchange: GPC) today announced a significant expansion of its drug development and clinical development capabilities thro ...Martinsried (Germany)March
To solve this challenge, Biotech Fluidics created the DEGASi Plus GPC and DEGASi Plus GPC Semi-Prep. These unique high-performance degassers can be used with all common organic solvents, including hexane and chlorinated solvents, by stenting the degasser membrane. This secure internal connection i...
Bachem AG Company type:Leading producer About Bachem Bachem is a listed technology-based company focused on peptide chemistry. The company provides a full range of services to the pharma and biotech industries. It specializes in the development of innovative, efficient manufacturing processes and the ...
Ramsey Baghdadi
GPC BIOTECH.The article reports that chemical company GPC Biotech AG is laying off 38 of its 101 employees as part of a cost-cutting move. 49 of the company's remaining employees will be in Princeton, New Jersey and the rest will be in Munich, Germany....
Gpc biotech AG. (Markets: Life sciences).(alliance with BYK Gulden Lomberg Chemische Fabrik GmbH)(Brief Article)
Presents information on the license agreement signed by GPC Biotech AG with Debiopharm SA for the pre-clinical small molecule major histocompatibility complex class II antagonists program for the treatment of autoimmune diseases. Scope and terms of the agreement; Details of the therapeutic mechanism of...
GPC Biotech and Agennix Announce Proposed MergerGPC Biotech AG and Agennix, Incorporated announced that the two oncology-focused biotechnology companies have signed a Business Combination Agreement under which they propose to merge their busin ...GPC Biotech AGAgennix...
The article reports on the merger of GPC Biotech AG and Agennix Inc. The partnership aims to widen and continue their oncology pipelines. The merged companies will receive $19,000 million cash infusion from the investment of Dietmar Hopp. The merger for GPC Biotech is a portion of an ...